Quanterix launches PhenoCode 2.0 kit. Wall Street Zen upgrades Quanterix stock to Hold

Published on 10/05/2026 at 01:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Quanterix posted USD 32.91 million revenue in the second quarter of 2026, up 34.00 percent year over year. Quanterix stock stands at a USD 171.5 million market value.

QTRX, US74766Q1013, Illustration mit AI erstellt.

Quanterix Corporation (US74766Q1013) released the PhenoCode 2.0 molecular barcoding kit on September 25, 2026, while Wall Street Zen upgraded Quanterix stock from Sell to Hold on September 19, 2026, as reported by MarketBeat. The company also confirmed two additional spatial biology panel shipments for the fourth quarter of 2026.

Spatial biology adds commercial products

According to Quanterix on September 25, 2026, the PhenoCode 2.0 kit moved from early access to full commercial release and became available to order globally. The TIME panel and a high-plex ADC panel are scheduled for shipment in the fourth quarter of 2026, extending the company's Content Innovation Engine beyond its initial research previews.

Quanterix said one of three programs presented at the American Association for Cancer Research meeting had already shipped, while the two remaining programs were confirmed for fourth-quarter delivery. The Accelerator Laboratory is also accepting custom ADC panel development requests for biopharma and translational research teams.

Revenue growth meets a wider loss

Quanterix generated USD 32.91 million of revenue in the second quarter of 2026, up 34.00 percent from USD 24.50 million a year earlier, according to the StockTitan summary of the August 10, 2026 filing. GAAP gross margin was 38.50 percent, while the company posted a net loss of USD 48.93 million compared with USD 30.00 million in the year-earlier quarter.

The same August 10, 2026 filing summary says Quanterix reduced its 2026 revenue outlook to USD 142 million to USD 148 million from USD 169 million to USD 173 million. It also set a non-GAAP gross margin outlook of 48.00 percent to 50.00 percent and moved expected cash-flow breakeven to 2027.

Market value remains below USD 200 million

QTRX last stood at USD 3.64 on Nasdaq on October 2, 2026 at 4:00 p.m. ET. Its 52-week range was USD 2.15 to USD 8.77, and its market capitalization was USD 171.5 million on October 2, 2026. The valuation leaves execution of the new spatial biology products and the revised revenue outlook as the central operating measures for the stock.